| Name | Safeway Pharmacy #0556 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 601 Broadway, Scottsbluff, Nebraska 69361 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (308) 635-1444 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
Researchers from the Research Institute Germans Trias i Pujol, the Biomedical Research Networking Center on Cardiovascular Diseases, the University of Barcelona and the the Universitat Politècnica de Catalunya have created a new field probe to detect in a non-invasive and non-ionizing way the presence of metallic stents as well as their potential structural failures through microwave spectrometry.
A report released today has found thousands of lives and billions of dollars could be saved annually by preventing stroke and improving access to treatment and care.
Despite the implementation of the Massachusetts health care reform designed to bolster employer-based insurance and to provide no-cost or low-cost insurance to those unable to afford it, the uninsured in Massachusetts remain predominantly the working poor, according to a new study by researchers at Harvard Medical School just published online in the Journal of General Internal Medicine.
› Verified 5 days ago
| NPI Number | 1003845025 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #0556 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 601 Broadway, Scottsbluff, NE 69361 |
| Phone Number | 308-635-1444 |
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
Researchers from the Research Institute Germans Trias i Pujol, the Biomedical Research Networking Center on Cardiovascular Diseases, the University of Barcelona and the the Universitat Politècnica de Catalunya have created a new field probe to detect in a non-invasive and non-ionizing way the presence of metallic stents as well as their potential structural failures through microwave spectrometry.
A report released today has found thousands of lives and billions of dollars could be saved annually by preventing stroke and improving access to treatment and care.
Despite the implementation of the Massachusetts health care reform designed to bolster employer-based insurance and to provide no-cost or low-cost insurance to those unable to afford it, the uninsured in Massachusetts remain predominantly the working poor, according to a new study by researchers at Harvard Medical School just published online in the Journal of General Internal Medicine.
› Verified 5 days ago
News Archive
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
Researchers from the Research Institute Germans Trias i Pujol, the Biomedical Research Networking Center on Cardiovascular Diseases, the University of Barcelona and the the Universitat Politècnica de Catalunya have created a new field probe to detect in a non-invasive and non-ionizing way the presence of metallic stents as well as their potential structural failures through microwave spectrometry.
A report released today has found thousands of lives and billions of dollars could be saved annually by preventing stroke and improving access to treatment and care.
Despite the implementation of the Massachusetts health care reform designed to bolster employer-based insurance and to provide no-cost or low-cost insurance to those unable to afford it, the uninsured in Massachusetts remain predominantly the working poor, according to a new study by researchers at Harvard Medical School just published online in the Journal of General Internal Medicine.
› Verified 5 days ago
Bluffs Vision Care Pc Type: Medicare Supplier Location: 416 Valley View Dr, Scottsbluff, Nebraska 69361 Phone: (308) 635-1633 | |
High Plains Orth & Pros Inc. Type: Medicare Supplier Location: 1930 E. 20th Place, Scottsbluff, Nebraska 69361 Phone: (308) 632-4641 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 410 S Beltline Hwy W, Scottsbluff, Nebraska 69361 Phone: (308) 632-8309 | |
Orthotic Prosthetic Solutions Type: Prosthetic/Orthotic Supplier Location: 1012 West 36th Street, Scottsbluff, Nebraska 69361 Phone: (720) 652-0100 | |
Safeway Pharmacy #0556 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 601 Broadway, Scottsbluff, Nebraska 69361 Phone: (308) 635-1444 |